MedTrace receives U.S. patent for diagnosing the human heart

MedTrace receives U.S. patent for diagnosing the human heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens […]

15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use

15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans” Harms, PhD, Senior Scientist at MedTrace, are contributing to the November issue of Society of Nuclear Medicine and Molecular Imaging (SNMMI)’s Value Initiative Newsletter. Lubberink & Harms elaborate on the challenges of […]

MedTrace inaugurates U.S. headquarters in downtown Minneapolis

MedTrace inaugurates U.S. headquarters in downtown Minneapolis Danish-born MedTrace is opening its new U.S. headquarters in Minneapolis’ IDS Center on September 7, 2022. The company expects to grow from 4 to 10 US-based employees within the next 12 months, and co-founder and COO Rune Wiik Kristensen will add “U.S. President” to his title when he […]

MedTrace Announces First Subject Scanned in Phase 3 Clinical Trial

MedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark Multiple Sites Involved Across the United States, Denmark, Sweden, and The Netherlands The Global Trial is Expected to Continue for 12 Months MedTrace Pharma A/S, a pharma and device company […]

MedTrace expands management with financial strategist as CFO

MedTrace expands management and appoints financial strategist heavyweight as CFO Ann Kristin Led, former Exec. Vice President of Finance and Strategy at pharma company MC2 Therapeutics, is the new CFO at MedTrace from April 1. She will join CEO Martin Stenfeldt and COO Rune Wiik Kristensen as part of management and play a vital role […]

MedTrace announces IND approval of RAPID-WATER phase 3 clinical trial

MedTrace Pharma announces IND approval with the initiation of RAPID-WATER phase 3 clinical trial MedTrace Pharma A/S announced today the FDA approval of the company’s Investigational New Drug (IND) application and the approval to commence the RAPID-WATER clinical trial to evaluate the use of 15O-water PET in diagnosing Coronary Artery Disease (CAD). The global trial […]

MedTrace Pharma takes step towards CE marking

MedTrace Pharma takes step towards CE marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with an eye to CE marking. The notified body, BSI, is based in the Netherlands. “We’re encouraged that BSI has agreed to audit our products,” says Rune Wiik Kristensen of MedTrace […]

MedTrace Installs P3 System at Sahlgrenska University Hospital

MedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation of a new P3 production and infusion system providing up to 1000 doses of 15O-water per year for the next five years. The Gothenburg-based hospital, one of the largest in […]